Carregant...

Serotonin: a novel bone mass controller may have implications for alveolar bone

As recent studies highlight the importance of alternative mechanisms in the control of bone turnover, new therapeutic approaches can be envisaged for bone diseases and periodontitis-induced bone loss. Recently, it has been shown that Fluoxetine and Venlafaxine, serotonin re-uptake inhibitors commonl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Galli, Carlo, Macaluso, Guido, Passeri, Giovanni
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3766083/
https://ncbi.nlm.nih.gov/pubmed/23964727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-5751-12-12
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!